An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.

Dividend stocks (which commonly are value stocks, but can be growth stocks) are great ways to drive long-term performance of ...

Various factors determine the best time to take your blood sugar medications, including how the medication works and its side effects.

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.

The Food and Drug Administration on Monday approved a pill version of the blockbuster weight-loss injectable drug Wegovy, ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo ...

Novo Nordisk gained a head start in the GLP-1 race but then fell behind; Pfizer is working hard to catch up to the new leader.

One of the main threads running through our most-read stories of 2025—as much as ever in the medtech industry writ large—is ...

Wegovy pill showed a mean weight loss of 16.6% in the OASIS 4 trial1Wegovy pill is indicated to reduce excess body weight and maintain weight reduction long-term and to reduce the risk of major advers ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk ...

Aficamten, a first-in-class cardiac myosin inhibitor, offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed ...